Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India

Table 1

Drugs affected by mutations detected in six of the thirty-seven recently HIV positive individuals in RT-region of pol gene.

High Risk group/State	AGE& gender	NRTI	NNRTI	Drugs Affected
MSM Haryana	26/Male	L74V		Intermediate Resistance: Abacavir ( ABC)
IDU Chandigarh	44/Male	K219N		Potential Low Level Resistance: Zidovudine (AZT)
FSW Chandigarh	25/Female	K219R		Potential Low Level Resistance: Zidovudine (AZT)
FSW Chandiagrh	38/Female	K219R		Potential Low Level Resistance: Zidovudine (AZT)
IDU Chandigarh	21/Male		Y181C	High-Level resistance: Nevirapine (NVP)
				Intermediate Resistance: efavirenz (EFV), etravirine (ETR), rilpivirine (RPV)
IDU Chandigarh	32/Male		Y181C	High-Level resistance: Nevirapine (NVP)
				Intermediate Resistance: efavirenz (EFV), etravirine (ETR), rilpivirine (RPV)